Cantor Fitzgerald initiated coverage of Structure Therapeutics with an Overweight rating and $65 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Cantor Fitzgerald initiated coverage of Structure Therapeutics with an Overweight rating and $65 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>